Cara Therapeutics (CARA) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cara Therapeutics Short Interest DataCara Therapeutics (CARA) has a short interest of 66,500 shares, representing 1.74% of the float (the number of shares available for trading by the public). This marks a -9.89% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.4, indicating that it would take 2.4 days of the average trading volume of 23,217 shares to cover all short positions.Current Short Interest66,500 sharesPrevious Short Interest73,800 sharesChange Vs. Previous Month-9.89%Dollar Volume Sold Short$337,155.00Short Interest Ratio2.4 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares4,574,000 sharesFloat Size3,820,000 sharesShort Percent of Float1.74%Today's Trading Volume237,144 sharesAverage Trading Volume23,217 sharesToday's Volume Vs. Average1,021% Short Selling Cara Therapeutics? Sign up to receive the latest short interest report for Cara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCARA Short Interest Over TimeCARA Days to Cover Over TimeCARA Percentage of Float Shorted Over Time Cara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202566,500 shares $337,155.00 -9.9%1.7%2.4 $5.07 3/15/202573,800 shares $378,594.00 +13.7%1.9%0.6 $5.13 2/28/202564,900 shares $310,222.00 -2.3%1.7%0.5 $4.78 2/15/202566,400 shares $345,280.00 +4.4%1.7%0.5 $5.20 1/31/202563,600 shares $307,824.00 -47.5%1.7%0.5 $4.84 1/15/2025121,100 shares $540,106.00 -15.1%3.2%0.8 $4.46 12/31/2024142,600 shares $872,712.00 -56.7%3.7%1 $6.12 12/15/2024329,400 shares $86,302.80 -42.9%0.7%0.2 $0.26 11/30/2024576,700 shares $175,316.80 -54.2%1.3%1.1 $0.30 11/15/20241,260,000 shares $391,986.00 +33.7%2.8%2.5 $0.31 Get the Latest News and Ratings for CARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024942,500 shares $292,552.00 +54.6%2.1%2 $0.31 10/15/2024609,700 shares $155,473.50 -26.7%1.3%1.9 $0.26 9/30/2024832,200 shares $256,317.60 -31.2%1.8%1.6 $0.31 9/15/20241,210,000 shares $317,625.00 +9.0%2.6%1.7 $0.26 8/31/20241,110,000 shares $399,600.00 -24.0%2.4%1.3 $0.36 8/15/20241,460,000 shares $474,500.00 +73.2%3.2%1.7 $0.33 7/31/2024842,900 shares $293,413.49 +37.4%1.9%1 $0.35 7/15/2024613,400 shares $205,489.00 -68.2%1.4%0.7 $0.34 6/30/20241,930,000 shares $497,940.00 -15.0%4.2%2.8 $0.26 6/15/20242,270,000 shares $794,500.00 -1.3%5.0%3.9 $0.35 5/31/20242,300,000 shares $1.49 million -5.7%5.1%6 $0.65 5/15/20242,440,000 shares $1.85 million -6.5%5.2%4.4 $0.76 4/30/20242,610,000 shares $1.96 million No Change5.6%4.4 $0.75 4/15/20242,610,000 shares $1.85 million +1.2%5.6%4.1 $0.71 3/31/20242,580,000 shares $2.35 million +4.0%5.6%3.7 $0.91 3/15/20242,480,000 shares $2.18 million +3.8%5.3%3.1 $0.88 2/29/20242,390,000 shares $2.03 million +7.2%5.2%2.5 $0.85 2/15/20242,230,000 shares $1.33 million -11.2%4.8%2.5 $0.60 1/31/20242,510,000 shares $1.42 million +5.5%5.4%3.2 $0.57 1/15/20242,380,000 shares $1.36 million +3.0%5.1%3.1 $0.57 12/31/20232,310,000 shares $1.72 million +6.5%5.0%3.1 $0.74 12/15/20232,170,000 shares $2.67 million -38.9%4.7%3.2 $1.23 11/30/20233,550,000 shares $3.43 million +3.8%7.7%6.2 $0.97 11/15/20233,420,000 shares $3.83 million +15.2%7.4%5.6 $1.12 10/31/20232,970,000 shares $3.83 million +9.6%6.6%5 $1.29 10/15/20232,710,000 shares $3.85 million +9.7%6.0%4.1 $1.42 9/30/20232,470,000 shares $4.15 million +10.3%5.5%3.5 $1.68 9/15/20232,240,000 shares $5.24 million +44.5%5.0%2 $2.34 8/31/20231,550,000 shares $3.98 million -40.8%3.5%1.2 $2.57 8/15/20232,620,000 shares $7.86 million -24.5%5.8%1.9 $3.00Massive new energy source found in Utah (Ad)NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.Find out what billionaires already know about this new energy source 7/31/20233,470,000 shares $11.56 million -12.6%8.1%2.5 $3.33 7/15/20233,970,000 shares $11.35 million +6.7%9.3%2.9 $2.86 6/30/20233,720,000 shares $10.53 million -35.3%8.7%2.8 $2.83 6/15/20235,750,000 shares $18.57 million +12.5%13.5%5.9 $3.23 5/31/20235,110,000 shares $16.25 million +2.0%12.0%6.8 $3.18 5/15/20235,010,000 shares $20.79 million No Change11.7%6.8 $4.15 4/30/20235,010,000 shares $21.04 million +3.5%11.9%7.5 $4.20 4/15/20234,840,000 shares $20.47 million -9.4%11.4%7.5 $4.23 3/31/20235,340,000 shares $26.22 million +3.9%12.6%8.6 $4.91 3/15/20235,140,000 shares $29.61 million -6.4%12.2%8.7 $5.76 2/28/20235,490,000 shares $55.78 million -1.4%13.0%11 $10.16 2/15/20235,570,000 shares $57.71 million +3.9%13.3%15.2 $10.36 1/31/20235,360,000 shares $62.60 million +6.4%12.8%15.3 $11.68 1/15/20235,040,000 shares $54.68 million +1.6%12.0%14.1 $10.85 12/30/20224,960,000 shares $53.27 million -10.8%11.8%13.8 $10.74 12/15/20225,560,000 shares $62.11 million -0.4%13.2%16.4 $11.17 11/30/20225,580,000 shares $65.84 million -9.4%13.3%16.5 $11.80 11/15/20226,160,000 shares $69.79 million -1.8%14.7%18.1 $11.33 10/31/20226,270,000 shares $58.94 million -1.7%14.9%17.1 $9.40 10/15/20226,380,000 shares $64.82 million -3.6%15.2%16.4 $10.16 9/30/20226,620,000 shares $61.96 million -7.2%15.8%16.4 $9.36 9/15/20227,130,000 shares $73.65 million No Change17.0%16.5 $10.33 8/31/20227,130,000 shares $73.58 million -0.7%17.0%16.4 $10.32 8/15/20227,180,000 shares $84.37 million -0.8%17.1%15.1 $11.75 7/31/20227,240,000 shares $63.28 million +3.0%16.3%12.6 $8.74 7/15/20227,030,000 shares $65.03 million +8.2%15.8%11.4 $9.25 6/30/20226,500,000 shares $59.35 million +3.5%14.6%10 $9.13 6/15/20226,280,000 shares $49.86 million +3.6%14.1%9.8 $7.94 5/31/20226,060,000 shares $50.42 million +13.3%13.6%9.1 $8.32 5/15/20225,350,000 shares $44.94 million +30.2%12.0%7.8 $8.40 4/30/20224,110,000 shares $35.84 million -2.4%9.2%6.9 $8.72 4/15/20224,210,000 shares $58.27 million +2.9%9.5%7.7 $13.84 3/31/20224,090,000 shares $49.69 million +1.0%9.2%8.2 $12.15 3/15/20224,050,000 shares $46.37 million +29.4%9.1%8.4 $11.45 2/28/20223,130,000 shares $32.46 million +25.2%7.1%6.3 $10.37 2/15/20222,500,000 shares $26.43 million +50.6%5.7%5.1 $10.57 1/31/20221,660,000 shares $19.22 million -4.6%3.8%3.2 $11.58 1/15/20221,740,000 shares $20.79 million -7.0%N/A0 $11.95 12/31/20211,870,000 shares $22.78 million -9.7%4.2%2.8 $12.18 12/15/20212,070,000 shares $25.83 million -19.8%4.7%3.1 $12.48 11/30/20212,580,000 shares $34.00 million +4.5%5.9%3.7 $13.18 11/15/20212,470,000 shares $38.63 million -14.8%5.6%2.7 $15.64 10/29/20212,900,000 shares $48.81 million +37.4%7.3%1.8 $16.83 10/15/20212,110,000 shares $27.77 million -0.5%5.3%1.4 $13.16 9/30/20212,120,000 shares $32.75 million -30.3%5.3%1.4 $15.45 9/15/20213,040,000 shares $44.90 million -21.5%7.6%2 $14.77 8/31/20213,870,000 shares $61.07 million +29.4%9.6%2.6 $15.78 8/13/20212,990,000 shares $41.41 million -2.0%7.4%4.3 $13.85 7/30/20213,050,000 shares $36.51 million No Change7.8%5.4 $11.97 7/15/20213,050,000 shares $39.47 million -3.8%7.8%3.6 $12.94Massive new energy source found in Utah (Ad)NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.Find out what billionaires already know about this new energy source 6/30/20213,170,000 shares $45.24 million -10.5%8.1%3.4 $14.27 6/15/20213,540,000 shares $50.20 million +12.4%9.0%2.8 $14.18 5/28/20213,150,000 shares $42.81 million -11.8%8.0%2.5 $13.59 5/14/20213,570,000 shares $45.98 million -7.8%9.1%2.9 $12.88 4/30/20213,870,000 shares $54.45 million +8.1%9.9%3 $14.07 4/15/20213,580,000 shares $102.10 million +30.7%9.3%3.8 $28.52 3/31/20212,740,000 shares $56.42 million -14.6%7.1%3.1 $20.59 3/15/20213,210,000 shares $61.95 million +4.6%8.3%6.3 $19.30 2/26/20213,070,000 shares $59.13 million +9.6%7.9%6.1 $19.26 2/12/20212,800,000 shares $55.75 million -4.4%7.2%5.8 $19.91 1/29/20212,930,000 shares $54.15 million -18.2%7.6%6.5 $18.48 1/15/20213,580,000 shares $64.62 million -6.8%9.2%8.2 $18.05 12/31/20203,840,000 shares $59.06 million -3.0%9.9%9.3 $15.38 12/15/20203,960,000 shares $59.00 million +2.9%10.2%9.3 $14.90 11/30/20203,850,000 shares $57.56 million +0.5%9.9%9.1 $14.95 11/15/20203,830,000 shares $59.02 million No Change10.1%9.3 $15.41 10/30/20203,830,000 shares $50.44 million -15.3%10.7%9.8 $13.17 10/15/20204,520,000 shares $60.52 million +2.5%12.6%11.6 $13.39 9/30/20204,410,000 shares $56.12 million +14.8%10.3%11.7 $12.73 9/15/20203,840,000 shares $58.56 million +2.4%9.0%10.3 $15.25 8/31/20203,750,000 shares $58.13 million +2.7%8.8%9.3 $15.50 8/14/20203,650,000 shares $59.46 million -1.1%8.5%8.5 $16.29 7/31/20203,690,000 shares $60.66 million -3.2%8.7%7.6 $16.44 7/15/20203,810,000 shares $68.28 million -5.0%9.0%7.4 $17.92 6/30/20204,010,000 shares $67.29 million +12.0%9.5%7.4 $16.78 6/15/20203,580,000 shares $55.56 million -2.2%8.5%6.6 $15.52 5/29/20203,660,000 shares $58.08 million -2.1%8.6%6.7 $15.87 5/15/20203,740,000 shares $56.25 million +14.0%8.8%6.6 $15.04 CARA Short Interest - Frequently Asked Questions What is Cara Therapeutics' current short interest? Short interest is the volume of Cara Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 66,500 shares of CARA short. 1.74% of Cara Therapeutics' shares are currently sold short. Learn More on Cara Therapeutics' current short interest. What is a good short interest ratio for Cara Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CARA shares currently have a short interest ratio of 2.0. Learn More on Cara Therapeutics's short interest ratio. Which institutional investors are shorting Cara Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cara Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cara Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.74% of Cara Therapeutics' floating shares are currently sold short. Is Cara Therapeutics' short interest increasing or decreasing? Cara Therapeutics saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 66,500 shares, a drop of 9.9% from the previous total of 73,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cara Therapeutics' float size? Cara Therapeutics currently has issued a total of 4,574,000 shares. Some of Cara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cara Therapeutics currently has a public float of 3,820,000 shares. How does Cara Therapeutics' short interest compare to its competitors? 1.74% of Cara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cara Therapeutics: Alector, Inc. (7.45%), Tonix Pharmaceuticals Holding Corp. (16.28%), Silence Therapeutics plc (5.41%), Coya Therapeutics, Inc. (2.16%), Immunic, Inc. (2.37%), Elutia Inc. (0.34%), Zura Bio Limited (5.59%), Genelux Co. (7.03%), OptiNose, Inc. (1.80%), Oramed Pharmaceuticals Inc. (2.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Cara Therapeutics stock? Short selling CARA is an investing strategy that aims to generate trading profit from Cara Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cara Therapeutics? A short squeeze for Cara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CARA, which in turn drives the price of the stock up even further. How often is Cara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CARA, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies ALEC Short Interest TNXP Short Interest SLN Short Interest COYA Short Interest IMUX Short Interest ELUT Short Interest ZURA Short Interest GNLX Short Interest OPTN Short Interest ORMP Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CARA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CARA Stock Free CARA Stock Alerts